Nuclear Export Inhibition for Pancreatic Cancer Therapy

by Irfana Muqbil, Asfar S. Azmi, Ramzi M. Mohammad
Published 2018-05-01

Progress in Nanotechnology Based Approaches to Enhance the Potential of Chemopreventive Agents

by Ramzi M. Mohammad, Fazlul H. Sarkar, Irfana Muqbil, Asfar S. Azmi, Ashiq Masood
Published 2011-01-01

The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma

by Maria Diab, Irfana Muqbil, Ramzi M. Mohammad, Asfar S. Azmi, Philip A. Philip
Published 2016-06-01

Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model

by Irfana Muqbil, Mahmoud Chaker, Amro Aboukameel, Ramzi M. Mohammad, Asfar S. Azmi, Radhakrishanan Ramchandren
Published 2019-08-01

DNA-Methylation-Caused Downregulation of <i>miR-30</i> Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma

by Asfar S. Azmi, Yiwei Li, Amro Aboukameel, Irfana Muqbil, Philip A. Philip, Ramzi M. Mohammad
Published 2019-08-01

Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells

by Md. Hafiz Uddin, Yiwei Li, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Rachel E. Sexton, Shriya Reddy, Yosef Landesman, Trinayan Kashyap, Asfar S. Azmi, Elisabeth I. Heath
Published 2021-06-01

Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance

by Husain Yar Khan, James Ge, Misako Nagasaka, Amro Aboukameel, Gabriel Mpilla, Irfana Muqbil, Mark Szlaczky, Mahmoud Chaker, Erkan Baloglu, Yosef Landesman, Ramzi M. Mohammad, Asfar S. Azmi, Ammar Sukari
Published 2019-12-01